FindTrial
Sign In

Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios

Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019882
Enrollment
Unknown
Registered
2018-12-05
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

NC Group:None
N-UAlb Group:None
M-UAlb group:None
L-UAlb group:None
L-UAlb+HP group:None

Sponsors

First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as T2DM; 2. Diagnosed as hypertension; 3. Aged 30 to 70 years.

Exclusion criteria

Exclusion criteria: 1. in the last 3 months acute diabetic complications, such as diabetic hyperosmotic coma ,diabetic ketoacidosis, etc; 2. intentional cerebrovascular disease, liver function damage, infectious disease and history of malignant tumor; 3. with recent stress conditions, such as infection, surgery, trauma,etc or special physical conditions, such as pregnancy and lactation; 4. patients in L-UAlb+HP group were treated by ACEI or ARB.

Design outcomes

Primary

MeasureTime frame
VASH-1;—

Secondary

MeasureTime frame
Fasting plasma glucose;Fasting plasma insulin;—

Countries

China

Contacts

Public ContactHuiwen Ren

First Hospital of China Medical University

rhwcmu@163.com+86 13940302241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026